BMI: Still Going Strong at Age 50 DOI
Jaime M. Moore, Stephen R. Daniels

PEDIATRICS, Journal Year: 2024, Volume and Issue: 154(1)

Published: June 3, 2024

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update DOI Open Access
Susan L. Samson, Priyathama Vellanki, Lawrence Blonde

et al.

Endocrine Practice, Journal Year: 2023, Volume and Issue: 29(5), P. 305 - 340

Published: May 1, 2023

Language: Английский

Citations

216

Definition and diagnostic criteria of clinical obesity DOI
Francesco Rubino,

David E. Cummings,

Robert H. Eckel

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

121

Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation DOI Creative Commons
Sarah Nutter, Laura Ann Eggerichs, Taniya S. Nagpal

et al.

Obesity Reviews, Journal Year: 2023, Volume and Issue: 25(1)

Published: Oct. 17, 2023

Summary Weight stigma, defined as pervasive misconceptions and stereotypes associated with higher body weight, is both a social determinant of health human rights issue. It imperative to consider how weight stigma may be impeding promotion efforts on global scale. The World Obesity Federation (WOF) convened working group practitioners, researchers, policymakers, youth advocates, individuals lived experience obesity the ways that narratives contribute stigma. Specifically, focused overall narratives, food physical activity scientific public‐facing language impact across lifespan was also considered. Taking perspective, nine recommendations resulted from this work for research can help reduce harmful inside outside contexts.

Language: Английский

Citations

83

Obesity and diabetes DOI
Chrysoula Boutari,

Antea DeMarsilis,

Christos S. Mantzoros

et al.

Diabetes Research and Clinical Practice, Journal Year: 2023, Volume and Issue: 202, P. 110773 - 110773

Published: June 24, 2023

Language: Английский

Citations

60

Nutritional considerations with antiobesity medications DOI Creative Commons
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury

et al.

Obesity, Journal Year: 2024, Volume and Issue: 32(9), P. 1613 - 1631

Published: June 10, 2024

The improved efficacy and generally favorable safety profile of recently approved emerging antiobesity medications (AOMs), which result in an average weight reduction ≥15%, represent significant advancement the treatment obesity. This narrative review aims to provide practical evidence-based recommendations for nutritional assessment, management, monitoring patients treated with AOMs. Prior treatment, clinicians can identify preexisting risk factors counsel their on recommended intakes protein, dietary fiber, micronutrients, fluids. During AOMs, ongoing facilitate early recognition management gastrointestinal symptoms or inadequate nutrient fluid intake. Attention should also be paid other that impact response quality life, such as physical activity social emotional health. In context play active role supporting obesity improve health well-being promote optimal medical outcomes.

Language: Английский

Citations

24

Experiences and overall impact reported by people living with obesity: results from a multinational study DOI Creative Commons

Esther Artime,

Swarna Khare,

Sarah Zimner‐Rapuch

et al.

SAGE Open Medicine, Journal Year: 2025, Volume and Issue: 13

Published: Jan. 1, 2025

To explore the impact of obesity on clinical outcomes, health-related quality life, emotional well-being, and work productivity in people/patients with across six countries by body mass index presence complications. Adelphi Real World Obesity Disease Specific Programme™ captured data related to physicians their consulting a weight management program or anti-obesity medication Brazil, Canada, China, Japan, Kingdom Saudi Arabia, United Arab Emirates from April December 2022. Physicians reported for up eight qualifying obesity. People/patients voluntarily completed outcome measures: 36-Item Short Form Health Survey, Work Productivity Activity Impairment. Of 1506 obesity, 58% were female (mean ± standard deviation age: 41 12.7 years; index: 32.3 kg/m2 7.7 kg/m2). Overall, 82% had ⩾1 complication (median interquartile range: 2.0 (1.0-3.0)). struggled mean SD 64.1 86.6 months median (interquartile range) 3.0 (2.0-5.0) weight-loss attempts. Mean Survey scores above threshold showed impairment general health (42.3 11.5), social functioning (44.3 9.2), role-emotional (46.0 9.3), mental (45.7 9.6). complications similar impairment. bother/embarrassment about weight, 72% worried future gain. activity among (36%), overall (34%), presenteeism (31%). Findings Results suggest that alongside negatively impacts productivity, reinforcing need comprehensive interventions this complex issue.

Language: Английский

Citations

1

Facing Challenges for Reducing Weight Stigma in Public Health Policy and Practice DOI
Rebecca M. Puhl

Annual Review of Public Health, Journal Year: 2025, Volume and Issue: 46(1), P. 133 - 150

Published: April 4, 2025

The prevalence and harms of societal weight stigma have increased attention to its presence in public health approaches communication. Calls action from scholars, advocates, professionals emphasize the need address as a social justice issue eliminate harmful narratives that perpetuate bias discrimination messages, practices, policies. However, debates surrounding issues complicate, at times impair, efforts effectively this problem. Different (and sometimes opposing) perspectives include views about risks versus effects high body weight, use mass index (BMI) metric health, weight-normative (i.e., weight-centric) weight-inclusive treatment approaches, stigmatizing language used describe potential challenges when framing obesity disease. This review summarizes current evidence, debates, best practices related efforts.

Language: Английский

Citations

1

Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making DOI Creative Commons
Kimberly A. Gudzune, Lee M. Kaplan, Scott Kahan

et al.

Endocrine Practice, Journal Year: 2024, Volume and Issue: 30(10), P. 917 - 926

Published: June 18, 2024

Limited recent evidence exists regarding weight-reduction preferences among people with obesity in the United States (US). We assessed preferred magnitudes of weight reduction adults and how these differ by participant characteristics.

Language: Английский

Citations

6

The evolution of the understanding of obesity over the last 100 years DOI
Javier Gómez‐Ambrosi, Victoria Catalán, Gema Frühbeck

et al.

International Journal of Obesity, Journal Year: 2024, Volume and Issue: 49(2), P. 168 - 176

Published: Nov. 7, 2024

Language: Английский

Citations

6

GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now? DOI
Emir Muzurović, Volkan Yumuk, Manfredi Rizzo

et al.

Journal of Diabetes and its Complications, Journal Year: 2023, Volume and Issue: 37(12), P. 108647 - 108647

Published: Nov. 7, 2023

Language: Английский

Citations

11